S. Goodison

T. Sugino, S. Goodison, D. Tarin, 1999, Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology.

A Nomogram Derived by Combination of Demographic and Biomarker Data Improves the Noninvasive Evaluation of Patients at Risk for Bladder Cancer

M. Kattan, S. Goodison, Changhong Yu, 2016, Cancer Epidemiology, Biomarkers & Prevention.

Diagnostic potential of urinary α1-antitrypsin and apolipoprotein E in the detection of bladder cancer.

S. Goodison, C. Rosser, Myron N. Chang, 2012, The Journal of urology.

IL-8 as a urinary biomarker for the detection of bladder cancer

S. Goodison, C. Rosser, Myron N. Chang, 2012, BMC Urology.

Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection.

S. Goodison, C. Rosser, Myron N. Chang, 2012, Urology.

Rapid analysis of distinctive CD44 RNA splicing preferences that characterize colonic tumors.

T. Sugino, S. Goodison, D. Tarin, 1997, Cancer research.

Application of a multiplex urinalysis test for the prediction of intravesical BCG treatment response: A pilot study

S. Goodison, A. Kamat, H. Furuya, 2021, Cancer biomarkers : section A of Disease markers.

Expression of CXCL1 in human endothelial cells induces angiogenesis through the CXCR2 receptor and the ERK1/2 and EGF pathways

S. Goodison, C. Rosser, M. Miyake, 2013, Laboratory Investigation.

Angiogenin promotes tumoral growth and angiogenesis by regulating matrix metallopeptidase-2 expression via the ERK1/2 pathway

S. Goodison, C. Rosser, M. Miyake, 2014, Oncogene.

MG289 in Mycoplasma genitalium Enhances Microbial Invasion and Bacterial Persistence in Benign Human Prostate Cells

S. Goodison, C. Rosser, W. Rizwani, 2013 .

Erythropoietin is a JAK2 and ERK1/2 effector that can promote renal tumor cell proliferation under hypoxic conditions

S. Goodison, Ge Zhang, C. Rosser, 2013, Journal of Hematology & Oncology.

Persistent Exposure to Mycoplasma Induces Malignant Transformation of Human Prostate Cells

K. Iczkowski, S. Goodison, C. Rosser, 2009, PloS one.

Detection of antibodies directed at M. hyorhinis p37 in the serum of men with newly diagnosed prostate cancer

S. Goodison, Chen-zhong Li, C. Rosser, 2011, BMC Cancer.

Complete Genome Sequence of Mycoplasma hyorhinis Strain SK76

S. Goodison, C. Rosser, Dibyendu Kumar, 2013, Genome Announcements.

Multiple intron retention occurs in tumor cell CD44 mRNA processing.

S. Goodison, D. Tarin, M. Churchman, 1998, The American journal of pathology.

CD44 cell adhesion molecules.

S. Goodison, D. Tarin, V. Urquidi, 1999, Molecular pathology : MP.

PAI-1 Leads to G1-Phase Cell-Cycle Progression through Cyclin D3/cdk4/6 Upregulation

S. Goodison, C. Rosser, M. Miyake, 2014, Molecular Cancer Research.

Cell Cycle and Senescence PAI-1 Leads to G 1-Phase Cell-Cycle Progression through Cyclin D 3 / cdk 4 / 6 Upregulation

S. Goodison, C. Rosser, M. Miyake, 2014 .

Immune Responses and Risk of Triple-negative Breast Cancer: Implications for Higher Rates among African American Women

Daniel P. Wickland, Y. Asmann, D. Radisky, 2020, Cancer Prevention Research.

The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells.

S. Goodison, Ryung S. Kim, V. Urquidi, 2005, Cancer research.

Prognostic cancer gene signatures share common regulatory motifs

S. Goodison, Haiyan Hu, X. Li, 2017, Scientific Reports.

An invasion-independent pathway of blood-borne metastasis: a new murine mammary tumor model.

T. Sugino, S. Goodison, Toshimitsu Suzuki, 2002, The American journal of pathology.

Feature selection for unsupervised learning through local learning

Qi Mao, Jin Yao, Yijun Sun, 2015, Pattern Recognit. Lett..

Comprehensive karyotyping of the HT‐29 colon adenocarcinoma cell line

Steve Goodison, K. Arden, S. Goodison, 2002, Genes, chromosomes & cancer.

Tolfenamic acid-induced alterations in genes and pathways in pancreatic cancer cells

S. Goodison, R. Basha, Fan Zhang, 2017, Oncotarget.

Cellular and Organismal Toxicity of the Anti-Cancer Small Molecule, Tolfenamic Acid: a Pre-Clinical Evaluation

D. Eslin, S. Goodison, R. Basha, 2013, Cellular Physiology and Biochemistry.

Pathway-BasedFeature Selection Algorithm for Cancer Microarray Data

Sanjay Ranka, Tamer Kahveci, Yijun Sun, 2010, Adv. Bioinformatics.

Proteomic profiling identifies breast tumor metastasis‐associated factors in an isogenic model

Steve Goodison, Paweena Kreunin, David M Lubman, 2007, Proteomics.

Cancer progression modeling using static sample data

Steve Goodison, Yijun Sun, S. Goodison, 2014, Genome Biology.

VEGF induces expression of Bcl-2 and multiple signaling factors in microvascular endothelial cells in a prostate cancer model

Wengang Cao, S. Goodison, C. Rosser, 2009, World Journal of Urology.

Chemokine (C-X-C motif) ligand 1 (CXCL1) protein expression is increased in high-grade prostate cancer.

S. Goodison, C. Rosser, M. Miyake, 2014, Pathology, research and practice.

Genomic signatures of breast cancer metastasis

S. Goodison, V. Urquidi, 2007, Cytogenetic and Genome Research.

Role of telomerase in cell senescence and oncogenesis.

S. Goodison, D. Tarin, V. Urquidi, 2000, Annual review of medicine.

Telomerase reverse transcriptase promoter regulation during myogenic differentiation of human RD rhabdomyosarcoma cells.

S. Goodison, V. Urquidi, Hongwen Ma, 2003, Molecular cancer research : MCR.

Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications.

B. Warren, T. Sugino, S. Goodison, 1997, British Journal of Cancer.

Telomerase activity in human breast cancer and benign breast lesions: Diagnostic applications in clinical specimens, including fine needle aspirates

Kazuhiro Yoshida, T. Sugino, S. Goodison, 1996, International journal of cancer.

Noninvasive diagnosis of bladder carcinoma by enzyme-linked immunosorbent assay detection of CD44 isoforms in exfoliated urothelia.

S. Goodison, D. Tarin, A. Woodman, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion

S. Goodison, P. Storz, H. Döppler, 2009, Breast Cancer Research.

Monoclonal Antibody against CXCL1 (HL2401) as a Novel Agent in Suppressing IL6 Expression and Tumoral Growth

W. Cai, S. Goodison, S. Anai, 2019, Theranostics.

Combination of PTEN gene therapy and radiation inhibits the growth of human prostate cancer xenografts.

K. Iczkowski, S. Goodison, S. Anai, 2006, Human gene therapy.

Molecular cytogenetic analysis of a human breast metastasis model: identification of phenotype-specific chromosomal rearrangements.

S. Goodison, V. Urquidi, C. Viars, 2005, Cancer genetics and cytogenetics.

A Two-Dimensional Liquid Mass Mapping Technique for Biomarker Discovery

Kathleen R. Cho, S. Goodison, R. Wu, 2008 .

Papillary carcinoma of the breast in a male patient with a treated prostatic carcinoma diagnosed by fine‐needle aspiration biopsy: A case report and review of the literature

S. Goodison, A. Ambaye, S. Masood, 2006, Diagnostic cytopathology.

A comparative phosphoproteomic analysis of a human tumor metastasis model using a label‐free quantitative approach

Steve Goodison, Yashu Liu, Xiaolei Xie, 2010, Electrophoresis.

Expression of matrix metalloproteinase 8 (MMP-8) and tyrosinase-related protein-1 (TYRP-1) correlates with the absence of metastasis in an isogenic human breast cancer model.

S. Goodison, D. Tarin, V. Urquidi, 2003, Differentiation; research in biological diversity.

Detection of differentially expressed genes in an isogenic breast metastasis model using RNA arbitrarily primed-polymerase chain reaction coupled with array hybridization (RAP-array).

S. Goodison, V. Urquidi, D. Sloan, 2004, The American journal of pathology.

The interrelationship between DRIM gene expression and cytogenetic and phenotypic characteristics in human breast tumor cell lines

S. Goodison, V. Urquidi, C. Viars, 2003, BMC Genomics.

Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis.

S. Goodison, D. Tarin, A. Woodman, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Improved breast cancer prognosis through the combination of clinical and genetic markers

Li Liu, Jian Li, Yijun Sun, 2007, Bioinform..

Elevated osteopontin and thrombospondin expression identifies malignant human breast carcinoma but is not indicative of metastatic status

J. Wang-Rodriguez, S. Goodison, V. Urquidi, 2003, Breast Cancer Research.

Dual targeting of Bcl-2 and VEGF: a potential strategy to improve therapy for prostate cancer.

Wengang Cao, S. Goodison, S. Anai, 2011, Urologic oncology.

A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort

S. Goodison, O. Ogawa, H. Furuya, 2016, Journal of Translational Medicine.

External Validation of a Multiplex Urinary Protein Panel for the Detection of Bladder Cancer in a Multicenter Cohort

T. Ørntoft, E. Zwarthoff, S. Goodison, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Urinary Protein Biomarker Panel for the Detection of Recurrent Bladder Cancer

S. Goodison, C. Rosser, A. Alcaraz, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Combining nomogram and microarray data for predicting prostate cancer recurrence

Yunpeng Cai, Yijun Sun, Steve Goodison, 2008, 2008 8th IEEE International Conference on BioInformatics and BioEngineering.

Differential expression of ribosomal proteins in a human metastasis model identified by coupling 2-D liquid chromatography and mass spectrometry.

S. Goodison, D. Lubman, V. Urquidi, 2007, Cancer genomics & proteomics.

Downregulation of BCL-2 induces downregulation of carbonic anhydrase IX, vascular endothelial growth factor, and pAkt and induces radiation sensitization.

S. Goodison, S. Anai, C. Rosser, 2007, Urology.

Soy isoflavones exert differential effects on androgen responsive genes in LNCaP human prostate cancer cells.

H. Baker, S. Goodison, Yuehua Cui, 2007, The Journal of nutrition.

Detection of exfoliated carcinoma cells in colonic luminal washings by identification of deranged patterns of expression of the CD44 gene.

B. Warren, T. Sugino, S. Goodison, 1996, Journal of clinical pathology.

Breast tumor metastasis: analysis via proteomic profiling

S. Goodison, V. Urquidi, 2008, Expert review of proteomics.

Bladder Cancer–Associated Gene Expression Signatures Identified by Profiling of Exfoliated Urothelia

Paul R Young, Steve Goodison, Li Liu, 2009, Cancer Epidemiology Biomarkers & Prevention.

Deep-learning approach to identifying cancer subtypes using high-dimensional genomic data

Le Yang, Steve Goodison, Runpu Chen, 2019, Bioinform..

Deep Learning Approach to Identifying Breast Cancer Subtypes Using High-Dimensional Genomic Data

Runpu Chen, Le Yang, Yijun Sun, 2019, bioRxiv.

Urinary BTA: indicator of bladder cancer or of hematuria

S. Goodison, C. Rosser, W. Rizwani, 2012, World Journal of Urology.

Influencing factors on the NMP-22 urine assay: an experimental model

S. Goodison, C. Rosser, W. Rizwani, 2012, BMC Urology.

Intravesical ALT-803 and BCG Treatment Reduces Tumor Burden in a Carcinogen Induced Bladder Cancer Rat Model; a Role for Cytokine Production and NK Cell Expansion

S. Goodison, Ge Zhang, C. Rosser, 2014, PloS one.

The cancer testis antigen PRAME as a biomarker for solid tumor cancer management.

S. Goodison, V. Urquidi, 2012, Biomarkers in medicine.

A novel phosphoprotein analysis scheme for assessing changes in premalignant and malignant breast cell lines using 2‐D liquid separations, protein microarrays, and tandem mass spectrometry

Tasneem H. Patwa, S. Goodison, F. Miller, 2008, Proteomics. Clinical applications.

Dimensionality Reduction Via Graph Structure Learning

Li Wang, Qi Mao, Yijun Sun, 2015, KDD.

Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signature

S. Goodison, Ge Zhang, H. Furuya, 2014, Diagnostic Pathology.

Increased expression of cyclooxygenase-2 correlates with resistance to radiation in human prostate adenocarcinoma cells.

S. Goodison, S. Anai, Motoyoshi Tanaka, 2007, The Journal of urology.

Insights into Mycoplasma genitalium metabolism revealed by the structure of MG289, an extracytoplasmic thiamine binding lipoprotein

Steve Goodison, Robert McKenna, Banumathi Sankaran, 2011, Proteins.

Sinusoidal tumor angiogenesis is a key component in hepatocellular carcinoma metastasis

T. Sugino, S. Goodison, Toshimitsu Suzuki, 2008, Clinical & Experimental Metastasis.

Genetic deletion of sphingosine kinase 1 suppresses mouse breast tumor development in an HER2 transgenic model

S. Goodison, A. Naing, H. Furuya, 2018, Carcinogenesis.

Urinary Glycoprotein Biomarker Discovery for Bladder Cancer Detection Using LC/MS-MS and Label-Free Quantification

K. Shedden, S. Goodison, C. Rosser, 2011, Clinical Cancer Research.

Local-Learning-Based Feature Selection for High-Dimensional Data Analysis

Sinisa Todorovic, Yijun Sun, Steve Goodison, 2010, IEEE Transactions on Pattern Analysis and Machine Intelligence.

Computational disease progression modeling can provide insights into cancer evolution

M. Sherman, S. Goodison, Yijun Sun, 2020, Oncoscience.

Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer

Y. Lotan, S. Goodison, Alvin Y. Liu, 2018, Oncotarget.

Urinary mRNA biomarker panel for the detection of urothelial carcinoma

D. Serie, S. Goodison, J. Eckel-Passow, 2016, Oncotarget.

A Candidate Molecular Biomarker Panel for the Detection of Bladder Cancer

Yunpeng Cai, Yijun Sun, S. Goodison, 2012, Cancer Epidemiology, Biomarkers & Prevention.

SimplePPT: A Simple Principal Tree Algorithm

Li Wang, Qi Mao, Le Yang, 2015, SDM.

Association of SNPs in the PAI1 Gene with Disease Recurrence and Clinical Outcome in Bladder Cancer

M. Thornquist, S. Goodison, H. Furuya, 2023, International journal of molecular sciences.

Diagnostic performance of Oncuria™, a urinalysis test for bladder cancer

S. Goodison, H. Furuya, C. Rosser, 2021, Journal of Translational Medicine.

A multiplex immunoassay for the non-invasive detection of bladder cancer

M. Thornquist, S. Goodison, H. Furuya, 2016, Journal of Translational Medicine.

Observed mRNA and Protein Isoforms

S. Goodison, D. Tarin, A. Woodman, 2007 .

Distribution of CD44 messenger RNA in archival paraffin wax embedded tumours and normal tissues viewed by in situ hybridisation

T. Sugino, S. Goodison, D. Tarin, 1996, Clinical molecular pathology.

Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling.

S. Goodison, C. Rosser, Jia Zhao, 2007, Journal of proteome research.

Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms.

T. Sugino, S. Goodison, D. Tarin, 1996, The American journal of pathology.

A Novel Aptamer Developed for Breast Cancer Cell Internalization

Steve Goodison, Weijia Sun, Guizhi Zhu, 2012, ChemMedChem.

Influencing Factors on the Oncuria™ Urinalysis Assay: An Experimental Model

S. Goodison, H. Furuya, C. Rosser, 2021, Diagnostics.

Deleted in Liver Cancer-1 (DLC1): An Emerging Metastasis Suppressor Gene

S. Goodison, N. Popescu, 2014, Molecular Diagnosis & Therapy.

Enrichment of glycoproteins using nanoscale chelating concanavalin A monolithic capillary chromatography.

S. Goodison, S. Pennathur, D. Lubman, 2009, Analytical chemistry.

Enrichment of glycoproteins using nanoscale chelating concanavalin A monolithic capillary chromatography.

S. Goodison, S. Pennathur, D. Lubman, 2009, Analytical chemistry.

Bladder Cancer Detection and Monitoring: Assessment of Urine- and Blood-Based Marker Tests

S. Goodison, C. Rosser, V. Urquidi, 2013, Molecular Diagnosis & Therapy.

Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.

R. Lotan, S. Goodison, D. Tarin, 2003, International journal of oncology.

CD24, a promising biomarker in NSCLC.

S. Goodison, C. Rosser, 2010, Biomarkers in medicine.

A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort

S. Goodison, O. Ogawa, H. Furuya, 2016, Journal of Translational Medicine.

Multiplex protein signature for the detection of bladder cancer in voided urine samples.

S. Goodison, Ge Zhang, C. Rosser, 2013, The Journal of urology.

BCL-2 MEDIATED MODULATION OF VASCULARIZATION IN PROSTATE CANCER XENOGRAFTS

Wengang Cao, S. Goodison, S. Anai, 2009 .

Bcl‐2 mediated modulation of vascularization in prostate cancer xenografts

Wengang Cao, S. Goodison, S. Anai, 2009, The Prostate.

A Facile Nanoparticle Immunoassay for Cancer Biomarker Discovery

M. Pensky, S. Goodison, Q. Huo, 2011, Journal of nanobiotechnology.

Genes in Stroma Diagnosis of Prostate Cancer Using Differentially Expressed

J. Wang-Rodriguez, Qiang Xu, Z. Jia, 2011 .

Gene Expression Profiling of Breast Cancer in Ethnic Populations: An Aid to Gene Discovery for the Benefit of All

S. Goodison, 2005, The breast journal.

Identification of metastasis‐associated proteins in a human tumor metastasis model using the mass‐mapping technique

S. Goodison, D. Lubman, V. Urquidi, 2004, Proteomics.

Predicting Breast Cancer Metastasis by Integrating Both Clinical and Genetic Markers

Yijun Sun, Steve Goodison, Yijun Sun, 2007, International Conference on Bioinformatics & Computational Biology.

16S ribosomal DNA amplification for phylogenetic study

S. Goodison, D. Lane, D. Pelletier, 1991, Journal of bacteriology.

An efficient and effective method to identify significantly perturbed subnetworks in cancer

Steve Goodison, Runpu Chen, Le Yang, 2021, Nature Computational Science.

Feature Selection for Nonlinear Regression and its Application to Cancer Research

Jin Yao, Yijun Sun, Steve Goodison, 2015, SDM.

CD44 expression in human breast cancer cell lines is related to oestrogen receptor (ER) status and confluency in vitro.

T. Sugino, S. Goodison, D. Tarin, 1997, Biochemical Society transactions.

Derivation of cancer diagnostic and prognostic signatures from gene expression data.

S. Goodison, Yijun Sun, V. Urquidi, 2010, Bioanalysis.

328. An Orthotopic Murine Model of Advanced Breast Cancer for Imaging and Comparison of Targeting Moieties

S. Goodison, D. Curiel, P. Laakkonen, 2005 .

Identifying Significantly Perturbed Subnetworks in Cancer Using Multiple Protein–Protein Interaction Networks

S. Goodison, Yijun Sun, Le Yang, 2023, Cancers.

Increased expression of cyclooxygenase-2 correlates with resistance to radiation in human prostate adenocarcinoma cells.

S. Goodison, S. Anai, Motoyoshi Tanaka, 2007 .

Improved breast cancer prognosis through the combination of clinical and genetic markers

Yijun Sun, Li Liu, W. Farmerie, 2007 .

Online Feature Selection Algorithm with Bayesian l1 Regularization

Jian Li, Yunpeng Cai, Yijun Sun, 2009, PAKDD.

A microRNA biomarker panel for the non-invasive detection of bladder cancer

D. Serie, S. Goodison, J. Eckel-Passow, 2016, Oncotarget.

Bioinformatics Original Paper Improved Breast Cancer Prognosis through the Combination of Clinical and Genetic Markers

Yijun Sun, Li Liu, W. Farmerie, 2022 .

Insights into Mycoplasma genitalium metabolism revealed by the structure of MG289, an extracytoplasmic thiamine binding lipoprotein

B. Sankaran, S. Goodison, R. McKenna, 2011, Proteins.

Morphological evidence for an invasion-independent metastasis pathway exists in multiple human cancers

T. Sugino, S. Goodison, Toshimitsu Suzuki, 2004, BMC medicine.

A comparative phosphoproteomic analysis of a human tumor metastasis model using a label‐free quantitative approach

S. Goodison, D. Lubman, Shun Feng, 2010, Electrophoresis.